Baird Medical Gains Indonesian Regulatory Approval for Microwave Ablation Technology

Baird Medical, a global leader in minimally invasive tumor ablation solutions, has received regulatory approval in Indonesia for its microwave ablation (MWA) technology, expanding access to advanced cancer treatment options in the region. This milestone strengthens Baird Medical’s presence in Southeast Asia and reinforces its commitment to delivering innovative, non-surgical therapies for patients.

Microwave ablation is a minimally invasive procedure that uses thermal energy to target and destroy tumors with precision and efficiency. With this approval, Indonesian healthcare providers will now have access to Baird Medical’s cutting-edge MWA technology, offering patients an alternative to traditional surgery with shorter recovery times and reduced complications.

"This regulatory approval marks a significant step in our global strategic expansion and underscores our commitment to improving patient care with cutting-edge, minimally invasive technologies," said Haimei Wu, Chairwoman of Baird Medical.  "We look forward to collaborating with Indonesian healthcare providers and supporting them with innovative solutions that enhance precision, safety, and patient outcomes.

Baird Medical continues to expand its global footprint, providing safe, effective, and minimally invasive cancer treatments to improve the quality of life for patients worldwide.